Consolidated Statement of Stockholders' Equity, Series A and Series B Convertible Preferred Stock (Unaudited) - USD ($) shares in Thousands, $ in Thousands |
Cumulative Effect, Period of Adoption, Adjustment [Member]
Common Stock [Member]
|
Cumulative Effect, Period of Adoption, Adjustment [Member]
Treasury Stock [Member]
|
Cumulative Effect, Period of Adoption, Adjustment [Member]
Additional Paid-in Capital [Member]
|
Cumulative Effect, Period of Adoption, Adjustment [Member]
Retained Earnings [Member]
|
Cumulative Effect, Period of Adoption, Adjustment [Member]
AOCI Attributable to Parent [Member]
|
Cumulative Effect, Period of Adoption, Adjustment [Member]
Series A Convertible Preferred Stock [Member]
|
Cumulative Effect, Period of Adoption, Adjustment [Member]
Series B Convertible Preferred Stock [Member]
|
Cumulative Effect, Period of Adoption, Adjustment [Member] |
Common Stock [Member] |
Treasury Stock [Member] |
Additional Paid-in Capital [Member] |
Retained Earnings [Member] |
AOCI Attributable to Parent [Member] |
Series A Convertible Preferred Stock [Member] |
Series B Convertible Preferred Stock [Member] |
Total |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Balance (in shares) at Dec. 31, 2018 | 106,856 | 6 | ||||||||||||||
Balance (Accounting Standards Update 2016-02 [Member]) at Dec. 31, 2018 | $ (213) | $ (213) | ||||||||||||||
Balance (Accounting Standards Update 2018-07 [Member]) at Dec. 31, 2018 | $ 2,116 | $ 2,116 | ||||||||||||||
Balance at Dec. 31, 2018 | $ 11 | $ (35) | $ 180,862 | $ (97,617) | $ 40,091 | $ 26,159 | $ 83,221 | |||||||||
Share-based compensation | 5,884 | 5,884 | ||||||||||||||
Restricted stock vesting (in shares) | 180 | |||||||||||||||
Restricted stock vesting | 495 | 495 | ||||||||||||||
Shares repurchased related to share-based compensation (in shares) | (65) | 65 | ||||||||||||||
Shares repurchased related to share-based compensation | $ (260) | (260) | ||||||||||||||
Preferred stock dividends | (4,972) | 3,133 | 1,819 | (4,972) | ||||||||||||
Deemed dividends - accretion of beneficial conversion feature | (551) | 551 | (551) | |||||||||||||
Net income | (12,043) | (12,043) | ||||||||||||||
Balance (in shares) at Mar. 31, 2019 | 106,971 | 71 | ||||||||||||||
Balance at Mar. 31, 2019 | $ 11 | $ (295) | 183,834 | (109,873) | 43,775 | 27,978 | 73,677 | |||||||||
Balance (in shares) at Dec. 31, 2019 | 117,329 | 137 | ||||||||||||||
Balance at Dec. 31, 2019 | $ 12 | $ (685) | 224,091 | (133,701) | 48,084 | 49,814 | 89,717 | |||||||||
Share-based compensation | (1,600) | (1,600) | ||||||||||||||
Restricted stock vesting (in shares) | 70 | |||||||||||||||
Restricted stock vesting | ||||||||||||||||
Shares repurchased related to share-based compensation (in shares) | (11) | 11 | ||||||||||||||
Shares repurchased related to share-based compensation | $ (57) | (57) | ||||||||||||||
Preferred stock dividends | (3,443) | 1,757 | 1,673 | (3,443) | ||||||||||||
Deemed dividends - accretion of beneficial conversion feature | (76) | 76 | (76) | |||||||||||||
Net income | 902 | 902 | ||||||||||||||
Balance (in shares) at Mar. 31, 2020 | 117,388 | 148 | ||||||||||||||
Balance at Mar. 31, 2020 | $ 12 | $ (742) | $ 218,972 | $ (132,799) | $ 49,917 | $ 51,487 | $ 85,443 |